ArticleClinical and translational science2024

Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals.

Hayase Hakariya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.